Feb 14, 2020|
JD Health’s New Online Platform Ensures Drug Supply to Chronic Disease Patients
By Hui Zhang
JD Health launched a new platform this week to help patients with chronic diseases maintain their drug supply during the coronavirus. In the first four days, the platform received nearly 10,000 requests and the number keeps rising.
Many patients with chronic disease in China’s Hubei province, where Wuhan is its capital, are running out of their medication, since some local hospitals and pharmacies have suspended regular services, traffic control was strengthened, and people are in quarantine or home-isolation during coronavirus outbreak. To address these challenges, this newly launched online platform connects chronic patients with pharmaceutical companies and pharmacies, and provides timely information on where they can get the drugs they need, online or offline.
Patients can upload their personal information, including symptoms and medications taken, onto the platform. At the same time, pharmaceutical companies and pharmacies can register with the platform and upload information regarding which medications they can supply. The platform will then match patients with pharmaceutical companies and pharmacies who can meet their needs. The data received thus far reveals that patients primarily struggle with maintaining critical conditions such as epilepsy, cerebral infarction, myasthenia gravis, and even cancer, among others.
Many well-known pharmaceutical companies both home and abroad have joined the program so far, including AstraZeneca, Bayer, Boehringer Ingelheim, and Chia Tai Tianqing Pharmaceutical Group, among others. In order to encourage more companies or pharmacies to come on board, JD Health promises to waive the platform commission generated by every valid drug order in Hubei province.
China’s National Health Commission has emphasized that internet medical services have played an important role in the fight against the coronavirus, and helped patients avoid cross-infections. Online medical consultation has quickly become a popular way to see a doctor since the outbreak of coronavirus. JD Health, a major player in the digital health sector, launched free online medical consultation services, ensured timely medical supply during the epidemic period, and provided free live-streams to ease people’s anxieties about the epidemic.